10 octubre 2014
Fighting oncogenes Cdk4 and Cdk6 with inhibitors that target both molecules is more effective than inhibiting them individually. These findings could have relevance in the further development of this group of drugs, which are already being tested successfully in breast cancer clinical trials.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/TLt_DgUQ7o8/141010101043.htm
